Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	23.59	30.41	33.46	50.01	64.4
Short-Term Investments	0.56	0.5	10.47	0.53	0.01
Cash & Short-Term Investments	24.15	30.91	43.93	50.54	64.41
Cash Growth	-21.86%	-29.64%	-13.09%	-21.53%	31317.56%
Accounts Receivable	4.86	3.57	4.13	2.32	0.05
Other Receivables	0.51	0.24	-	-	0.21
Receivables	5.37	3.81	4.13	2.32	0.25
Prepaid Expenses	0.19	0.59	1.75	1.1	1.95
Total Current Assets	29.71	35.31	49.8	53.96	66.61
Property, Plant & Equipment	1.99	2.15	1.06	0.3	0.18
Long-Term Investments	3.75	4.8	4.95	4.53	0.01
Other Intangible Assets	3.84	1.77	1.81	1.85	1.51
Long-Term Accounts Receivable	2.05	1.59	1.31	1.71	-
Long-Term Deferred Charges	-	2.06	1.68	1.09	0.87
Other Long-Term Assets	-	-	0.12	-	-
Total Assets	41.34	47.68	60.73	63.44	69.18
Accounts Payable	3.43	3.2	2.3	2.62	1.6
Accrued Expenses	-	0.12	0.07	0.08	0.03
Short-Term Debt	-	-	-	-	0.41
Current Portion of Long-Term Debt	-	-	-	8.62	-
Current Portion of Leases	0.33	0.24	0.14	0.07	0.05
Current Income Taxes Payable	-	-	-	0.35	0.05
Current Unearned Revenue	-	0.01	-	-	-
Other Current Liabilities	3.41	3.2	3.26	3.25	0.01
Total Current Liabilities	7.16	6.76	5.77	14.98	2.13
Long-Term Debt	-	-	-	-	7.89
Long-Term Leases	1.49	1.51	0.75	0.11	0.11
Other Long-Term Liabilities	0.54	0.34	0.3	0.3	-
Total Liabilities	9.19	8.61	6.82	15.39	10.12
Common Stock	0.14	0.14	0.14	0.13	0.13
Additional Paid-In Capital	121.51	121.51	121.51	103.69	103.69
Retained Earnings	-86.47	-80.76	-65.38	-54.81	-43.23
Comprehensive Income & Other	-3.04	-1.82	-2.36	-0.96	-1.54
Total Common Equity	32.14	39.07	53.91	48.06	59.06
Shareholders' Equity	32.14	39.07	53.91	48.06	59.06
Total Liabilities & Equity	41.34	47.68	60.73	63.44	69.18
Total Debt	1.82	1.75	0.89	8.79	8.45
Net Cash (Debt)	22.34	29.15	43.04	41.75	55.96
Net Cash Growth	-23.39%	-32.27%	3.09%	-25.39%	-
Net Cash Per Share	-	1.04	1.58	1.62	2.56
Filing Date Shares Outstanding	-	28	28	25.83	25.83
Total Common Shares Outstanding	-	28	28	25.83	25.83
Working Capital	22.55	28.55	44.03	38.98	64.48
Book Value Per Share	-	1.40	1.93	1.86	2.29
Tangible Book Value	28.31	37.3	52.1	46.2	57.55
Tangible Book Value Per Share	-	1.33	1.86	1.79	2.23

Updated Oct 16, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.